Concepedia

Author

Joep van der Leeuw

University Medical Center Utrecht

Also Known As

Franois Furet, J Van Der Leeuw, J Van der Heijden, J van der Leeuw, J. van der Leeuw, Joep van der Leeuw, R Cli

36

Publications

710

Citations

12

H-Index

20

Concepts

All Affiliations

University Medical Center UtrechtUniversity Medical Center GroningenUniversity of GroningenImperial College LondonOklahoma State University Center for Health Sciences
JV

About

Joep van der Leeuw is an author at University Medical Center Utrecht specializing in cardiovascular disease, epidemiology, and public health.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Public Health

2

2

77

2

Epidemiology

2

2

77

3

Medicine

1

1

66

4

Global Health

1

1

11

5

Health Informatics

1

1

66

Joep van der Leeuw

×

12

Publications

495

Citations

11

H-Index

YearCitations

Incorporating kidney disease measures into cardiovascular risk prediction: Development and validation in 9 million adults from 72 datasets

Kunihiro Matsushita, Simerjot K Jassal, Yingying Sang,

EClinicalMedicine

2020

107

Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus

Joep van der Leeuw, Joline W. J. Beulens, Susan van Dieren,

Journal of the American Heart Association

2016

77

Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

Kunihiro Matsushita, Stephen Kaptoge, Steven H J Hageman,

European Journal of Preventive Cardiology

2022

70

Personalized cardiovascular disease prevention by applying individualized prediction of treatment effects

Joep van der Leeuw, Paul M. Ridker, Y. van der Graaf,

European Heart Journal

2014

66

The Relation Between HbA1c and Cardiovascular Events in Patients With Type 2 Diabetes With and Without Vascular Disease

Guido Kranenburg, Yolanda van der Graaf, Joep van der Leeuw,

Diabetes Care

2015

49

Age-related differences in abdominal fat distribution in premenopausal and postmenopausal women with cardiovascular disease

Joep van der Leeuw, Annemarie M.J. Wassink, Yolanda van der Graaf,

Menopause The Journal of The North American Menopause Society

2012

29

Predicting the Effects of Blood Pressure–Lowering Treatment on Major Cardiovascular Events for Individual Patients With Type 2 Diabetes Mellitus

Joep van der Leeuw, Frank L.J. Visseren, Mark Woodward,

Hypertension

2014

25

The separate and combined effects of adiposity and cardiometabolic dysfunction on the risk of recurrent cardiovascular events and mortality in patients with manifest vascular disease

Joep van der Leeuw, Yolanda van der Graaf, Hendrik M. Nathoe,

Heart

2014

22

Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation

Manon C. Stam‐Slob, Stuart J. Connolly, Yolanda van der Graaf,

Circulation

2019

16

Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease

W Bakker, Hiddo J.L. Heerspink, Stefan P. Berger,

Nephrology Dialysis Transplantation

2025

13

Page 1